Abstract
BackgroundManagement of patients with recurrent endometrial cancer after failure of platinum therapy remains an important clinical challenge. Tumors characterized by abnormalities in DNA repair are associated with high numbers of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
